FDA says Vitamin Vape sold B12 VitaminVape as a drug without FDA approval and made drug claims online.
What happened
FDA reviewed https://www.vitaminvape.co in September 2021 and the company’s Facebook page. It found the site takes orders for B12 VitaminVape and that website and social media claims show the product is intended as a drug. FDA says the product is a drug that lacks FDA approval and that inhaling it raises safety concerns.
What FDA found
The website and Facebook claims show B12 VitaminVape is intended to affect the body or treat disease, making it a drug.
FD&C Act section 201(g)(1), 21 U.S.C. 321(g)(1)FDA says B12 VitaminVape is not generally recognized as safe and effective for those uses, so it is a new drug.
FD&C Act section 201(p), 21 U.S.C. 321(p)The company sells B12 VitaminVape without an FDA-approved application for the drug.
FD&C Act sections 505(a) and 301(d), 21 U.S.C. 355(a), 331(d)The product has a Nutrition Facts label even though FDA says it does not meet the definition of food.
FD&C Act section 201(f), 21 U.S.C. 321(f)FDA says inhaling the product’s ingredients or impurities may trigger airway spasm, harm airway tissues, or cause systemic effects.
What FDA wants
FDA asks the company to reply in writing within 15 working days of receipt with the specific steps taken to address the violations, how it will prevent recurrence, and supporting documentation. If the company believes it is not violating the law, it must include its reasoning and supporting information.
Who should pay attention
- companies selling inhaled vitamin or wellness vapes
- retailers and online marketplaces listing health-related vape products
- brands making drug-like claims on websites or social media
This is a summary. Read the original letter on fda.gov.